Apr 9, 2018 8:30 am EDT EyeGate Receives FDA Feedback on Investigational Device Exemption Amendment for Second Pilot Study of Ocular Bandage Gel
Apr 6, 2018 8:30 am EDT EyeGate Completes Enrollment and Receives Milestone Payment for Confirmatory Phase 3 Clinical Study of EGP-437 in Anterior Uveitis
Mar 8, 2018 8:30 am EST EyeGate Pharma Submits Investigational Device Exemption Amendment for Second Pilot Study of Ocular Bandage Gel
Mar 2, 2018 4:28 pm EST EyeGate Pharmaceuticals Reports Full-Year 2017 Financial Results and Provides Business Update
Feb 5, 2018 8:30 am EST EyeGate Announces Top-Line Results for Phase 2b Trial of EGP-437 in Cataract Surgery